Ghw Logo

5 - 7 April 2027
Vietnam Exposition Center, Hanoi

BROUGHT TO YOU BY

Vietnam's Blood Glucose Monitoring Market Set for Strong Growth as Diabetes Care Becomes Increasingly Digital

Vietnam's blood glucose monitoring market is growing through diabetes care, continuous monitoring, biosensors, and digital health.

Tuesday, 14 July 2026

News
Shutterstock 2668466815

Vietnam's blood glucose monitoring market is entering a new phase of growth as rising diabetes prevalence, increasing patient awareness and rapid advances in digital health technologies drive demand for more sophisticated glucose monitoring solutions.

Although a standalone valuation for Vietnam's blood glucose monitoring market is not publicly available, industry analysis estimates the sector is currently worth US$75–95 million in 2025 and is projected to reach US$110–145 million by 2030.

Blood glucose monitoring remains the cornerstone of diabetes management, enabling patients and healthcare professionals to monitor blood sugar levels, optimise treatment and reduce the risk of serious complications. The market includes traditional finger-prick blood glucose meters, continuous glucose monitoring (CGM) systems, flash glucose monitoring devices, test strips, lancets and connected digital monitoring platforms.

Several long-term trends are driving market growth across Vietnam:

  • Rising prevalence of type 2 diabetes driven by ageing, urbanisation and lifestyle changes.
  • Increasing diagnosis rates and greater awareness of diabetes management.
  • Growing adoption of continuous glucose monitoring (CGM) technologies.
  • Expansion of home healthcare and remote patient monitoring.
  • Integration of glucose monitoring devices with smartphone applications and cloud-based diabetes management platforms.
  • Improved access to diabetes care through expanding healthcare infrastructure.
  • Government initiatives promoting chronic disease prevention and management.

Vietnam's broader diabetes care sector provides a strong foundation for continued growth. According to IMARC Group, the country's diabetes care devices market reached US$139.2 million in 2025 and is forecast to grow to US$162.1 million by 2034. While overall growth is moderate, the strongest momentum is expected in continuous glucose monitoring and connected monitoring technologies as patients increasingly move beyond conventional blood glucose meters.

Point-of-care diagnostics are also supporting demand. IMARC Group estimates Vietnam's point-of-care diagnostics market reached US$230.5 million in 2025 and is projected to expand to US$465.4 million by 2034, with blood glucose monitoring kits representing one of the largest product categories. The continued decentralisation of healthcare and increased emphasis on rapid testing are expected to support wider adoption of glucose monitoring devices in hospitals, clinics and home settings.

The rapid development of biosensor technology is transforming diabetes management. According to IMARC Group, Vietnam's biosensors market reached US$131.7 million in 2025 and is forecast to grow to US$226.3 million by 2034. Blood glucose testing remains one of the largest applications, with advances in electrochemical biosensors improving device accuracy, reliability and ease of use.

Digital healthcare is also reshaping the market. Connected glucose monitors now synchronise with mobile applications, cloud platforms and telemedicine services, enabling clinicians to review glucose trends remotely and support more personalised diabetes care. Continuous glucose monitoring systems are increasingly integrated with insulin pumps and artificial intelligence-driven analytics, helping patients maintain tighter glycaemic control while reducing episodes of hypoglycaemia.

Leading manufacturers including AbbottDexcomRoche Diabetes CareAscensia Diabetes CareLifeScanMedtronicNovo NordiskYpsomed and Sinocare continue to introduce next-generation continuous glucose monitoring systems and connected diabetes management platforms, supporting the global shift towards digital diabetes care.

As Vietnam continues to strengthen chronic disease management and modernise its healthcare system, blood glucose monitoring technologies are expected to become increasingly important in improving outcomes for people living with diabetes. For manufacturers of glucose monitoring devices, biosensors, digital health platforms, diabetes software and connected medical technologies, Vietnam represents one of Southeast Asia's most promising long-term growth opportunities.

READ THE FULL INSIGHTS REPORT